TY - JOUR T1 - Evidence-based pandemic preparedness: an infrastructure for population-scale genome-based based testing for COVID-19 JF - medRxiv DO - 10.1101/2021.06.10.21258526 SP - 2021.06.10.21258526 AU - Hans Lehrach AU - Jon Curtis AU - Bodo Lange AU - Lesley A Ogilvie AU - Richard Gauss AU - Christoph Steininger AU - Erhard Scholz AU - Matthias Kreck Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/22/2021.06.10.21258526.abstract N2 - Our lives (and deaths) have been dominated for more than a year by COVID-19, a pandemic that has caused hundreds of millions of disease cases, millions of deaths, trillions in economic costs, and major restrictions on our freedom. We argue that much of this could have been avoided by repeated and systematic population-scale PCR-based testing and targeted quarantine. We describe key elements of the current implementations of such a system and demonstrate (with Germany as an example), that this strategy could have suppressed the pandemic within weeks, eliminating the vast majority of its overall impact in terms of deaths, economic costs and restrictions. It can, however, still play a major role in further reducing the worldwide impact of the current phase of the pandemic, and remain as a key protection against similar dangers in the future.Competing Interest StatementHL is co-founder and Chairman of the Company Board, and BL, JC and LO are employees of or con-sultants for Alacris Theranostics GmbH, a personal-ized medicine company which has developed a high throughput RT-PCR testing platform for SARS-CoV-2. CS is founder of LEAD Horizon, a COVID-19 testing company in Vienna. All other authors declare no competing interests.Funding StatementNo external fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe three notebooks used in this work are available for download through http://www2.math.uni-wuppertal.de/~scholz/model-epidem.htmlhttp://www2.math.uni-wuppertal.de/~scholz/model-epidem.html ER -